Published in Stroke on February 01, 1993
BMP7 reduces synergistic injury induced by methamphetamine and ischemia in mouse brain. Neurosci Lett (2008) 0.94
Ventricular fibrillation coinciding with phentermine initiation. BMJ Case Rep (2012) 0.89
Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke. Br J Clin Pharmacol (1999) 0.89
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology (2000) 4.13
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology (1998) 3.62
The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology (2007) 3.24
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med (1999) 2.82
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65
Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA (2001) 2.24
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke (1999) 2.17
A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity. Stroke (2001) 2.16
The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology (1995) 2.10
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology (2002) 2.02
Ataxic hemiparesis: critical appraisal of a lacunar syndrome. Stroke (1998) 1.98
Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine. Stroke (1995) 1.91
Cerebrovascular complications of Fabry's disease. Ann Neurol (1996) 1.78
A model to predict the histopathology of human stroke using diffusion and T2-weighted magnetic resonance imaging. Stroke (1995) 1.75
Low brain magnesium in migraine. Headache (1989) 1.70
Pilot study of functional MRI to assess cerebral activation of motor function after poststroke hemiparesis. Stroke (1998) 1.55
Time course of ADCw changes in ischemic stroke: beyond the human eye! Stroke (1998) 1.54
Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology (1998) 1.51
Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology (2000) 1.48
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation (2001) 1.48
Spectrum of patients with EMG features of polyradiculopathy without neuropathy. Muscle Nerve (1990) 1.40
Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke (2001) 1.38
Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology (2001) 1.37
Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience. Stroke (2000) 1.35
Cocaine and stroke. Stroke (1988) 1.27
Cerebellar infarction. Clinical and anatomic observations in 66 cases. Stroke (1993) 1.26
Cocaine-associated intracranial hemorrhage: absence of vasculitis in 14 cases. Neurology (1996) 1.17
Creatine use among young athletes. Pediatrics (2001) 1.17
The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies. Arch Neurol (1987) 1.14
Cerebral venous thrombosis and anticardiolipin antibodies. Stroke (1997) 1.13
Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology (2006) 1.13
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial. Stroke (2000) 1.12
Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group. Neurology (1999) 1.10
Crack-associated stroke. Neurology (1987) 1.09
Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology (2006) 1.08
Pursuing the promise of an information-age health care system. Health Aff (Millwood) (1999) 1.08
Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002. Lupus (2003) 1.04
Large cerebral vessel occlusive disease in systemic lupus erythematosus. Neurology (1994) 0.98
Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics. Neurology (1993) 0.97
Factors associated with early presentation of acute stroke. Stroke (1993) 0.96
Migraine-related stroke in the context of the International Headache Society classification of head pain. Arch Neurol (1990) 0.93
Masson's tumor of the kidney: a new renal lesion. J Urol (1990) 0.93
Cerebrovascular ischemia associated with lupus anticoagulant. Stroke (1987) 0.92
Cerebral venous thrombosis with lupus anticoagulants. Report of two cases. Stroke (1987) 0.92
Low brain magnesium in migraine. Headache (1989) 0.91
In vivo 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. Neurology (1989) 0.91
Hypomagnesemia and ventricular tachycardia: a complication of ulcerative colitis and parenteral hyperalimentation in a nondigitalized noncardiac patient. Chest (1982) 0.90
Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. Lupus (2003) 0.89
Stroke in patients with fusiform vertebrobasilar aneurysms. Neurology (1989) 0.88
Magnetic resonance spectroscopy in cerebral ischemia. Neurol Clin (1992) 0.87
Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke. Ann Neurol (2001) 0.87
Altered brain energy metabolism in demented patients with multiple subcortical ischemic lesions. Working hypotheses. Arch Neurol (1993) 0.87
Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain (2001) 0.86
Ventricular arrhythmias during exercise testing: mechanism, response to coronary bypass surgery and prognostic significance. Am J Cardiol (1984) 0.85
Intravenous thrombolysis for acute stroke. Neurology (1997) 0.84
Recurrent stroke associated with thymoma and anticardiolipin antibodies. Arch Neurol (1987) 0.84
Distribution of the 72-kd heat-shock protein as a function of transient focal cerebral ischemia in rats. Stroke (1992) 0.83
Cerebral blood flow changes with enalapril. Pharmacotherapy (1992) 0.83
Adhesive glycoproteins CD11a and CD18 are upregulated in the leukocytes from patients with ischemic stroke and transient ischemic attacks. J Neurol Sci (1995) 0.82
Polyradiculopathy in sarcoidosis. Muscle Nerve (1999) 0.82
Antiphospholipid-protein antibodies and ischemic stroke: not just cardiolipin any more. Stroke (1998) 0.81
Acute elevation and recovery of intracellular [Mg2+] following human focal cerebral ischemia. Neurology (1993) 0.81
Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology (1989) 0.81
Tissue plasminogen activator for acute ischemic stroke in patients with unruptured cerebral aneurysms. J Stroke Cerebrovasc Dis (2013) 0.81
Antiphospholipid antibodies and recurrent thrombo-occlusive events. Lancet (1992) 0.79
Rapid drop in serum iron concentration associated with stress. Am J Med Sci (1983) 0.79
Digital rectal examination, serum prostate specific antigen, and prostatic ultrasound: how effective is this diagnostic triad? J Surg Oncol (1994) 0.79
Regression of metastatic renal cell carcinoma: a case report and literature review. J Urol (1986) 0.79
Sensitivity to PAF is increased in migraine patients. Thromb Haemost (1987) 0.78
Bilateral posterior cerebral artery strokes in a young migraine sufferer. Stroke (1988) 0.78
Neuronal injury and expression of 72-kDa heat-shock protein after forebrain ischemia in the rat. Acta Neuropathol (1991) 0.78
Preliminary clinical-radiological assessment of a MR tissue signature model in human stroke. J Neurol Sci (1998) 0.78
Effect of nimodipine on blood pressure in acute ischemic stroke in humans. Stroke (1988) 0.78
Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke (1998) 0.77
Hypothermia reduces 72-kDa heat-shock protein induction in rat brain after transient forebrain ischemia. Stroke (1992) 0.77
Factors determining headache at onset of acute ischemic stroke. Cephalalgia (2006) 0.77
Distribution of 72-kDa heat-shock protein in rat brain after hyperthermia. Acta Neuropathol (1992) 0.77
Antiphospholipid-protein antibodies and acute ischemic stroke in the NINDS rt-PA Stroke Trial. Neurology (2003) 0.77
Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases. Neurology (1998) 0.77
The role of antiphospholipid antibodies in stroke. Neurol Clin (1992) 0.77
Stroke risk and age do not predict behavioral activation of brain blood flow. Ann Neurol (1989) 0.77
Atypical progressive stroke syndrome associated with oral contraceptives and cigarette use. Stroke (1987) 0.77
Cerebral blood flow in migraine accompaniments and vertebrobasilar ischemia. Stroke (1994) 0.77
Magnetic resonance and clinical cerebrovascular disease. An update. Stroke (1989) 0.76
The effects of aging on cerebral blood flow in migraine. Neurology (1989) 0.76
Transient ischemic attacks in the elderly: diagnosis and treatment. Geriatrics (1992) 0.76
Anticardiolipin antibodies and their associations with cerebrovascular risk factors. Neurology (1999) 0.76
Pathophysiological correlates of cerebral ischemia the significance of cellular acid base shifts. Funct Neurol (1990) 0.76
Migraine-like visual phenomena associated with cerebral venous thrombosis. Headache (1989) 0.76
Tax credits for both job-based and individual coverage. Health Aff (Millwood) (2001) 0.75
2001: A prospective, seasonal odyssey into antiphospholipid protein antibodies. Stroke (2001) 0.75
Clinical radiologic correlations in acute stroke: is the signal intensity at the end of the tunnel getting brighter quicker? J Neurol Neurosurg Psychiatry (2003) 0.75
Moyamoya syndrome associated with Sneddon's syndrome and antiphospholipid-protein antibodies. J Stroke Cerebrovasc Dis (2007) 0.75
Hypertension+MRI changes=impaired cognition. J Neurol Neurosurg Psychiatry (2002) 0.75
Immunologic testing in stroke patients. Stroke (1995) 0.75
Recreational drug use and stroke. Ann Intern Med (1991) 0.75
Migraine and the lupus anticoagulant. Case reports and review of the literature. Cephalalgia (1987) 0.75